CONSENT AND NINTH AMENDMENT TO LOAN AND SECURITY AGREEMENTPatent and Know-How License Agreement • March 30th, 2020 • Plus Therapeutics, Inc. • Surgical & medical instruments & apparatus • Texas
Contract Type FiledMarch 30th, 2020 Company Industry JurisdictionTHIS CONSENT AND NINTH AMENDMENT to Loan and Security Agreement (this “Amendment”) is made effective as of March 29, 2020 (the “Amendment Date”) and made, by and among OXFORD FINANCE LLC, a Delaware limited liability company with an office located at 133 North Fairfax Street, Alexandria, Virginia 22314 (in its individual capacity, “Oxford”; and in its capacity as Collateral Agent, “Collateral Agent”), the Lenders listed on Schedule 1.1 from time to time to the Loan Agreement (defined below) including Oxford in its capacity as a Lender (each a “Lender” and collectively, the “Lenders”) and PLUS THERAPEUTICS, INC., a Delaware corporation with offices located at 4200 Marathon Blvd., Suite 200, Austin, Texas 78756 (“Borrower”).
PATENT AND KNOW-HOW LICENSE AGREEMENTPatent and Know-How License Agreement • March 30th, 2020 • Plus Therapeutics, Inc. • Surgical & medical instruments & apparatus • Texas
Contract Type FiledMarch 30th, 2020 Company Industry JurisdictionTHIS PATENT AND KNOW-HOW LICENSE AGREEMENT (this “Agreement”) dated March 29, 2020 (the “Effective Date”) is by and among NanoTx, Corp., a corporation organized and existing under the laws of Delaware, having an address of 7979 Wurzbach Road, San Antonio, Texas 78229 (“NanoTx” or “Licensor”) and Plus Therapeutics, Inc., a corporation organized and existing under the laws of Delaware, having an address of 4200 Marathon Blvd., Suite 200, Austin, Texas 78756 (“PLUS” or “Licensee”). NanoTx and PLUS are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”